{
    "nctId": "NCT01925586",
    "briefTitle": "Atypical Lesions of the Breast: Close Observation Versus Excision (ALCOVE)",
    "officialTitle": "Atypical Lesions of the Breast: Close Observation vs. Excision",
    "overallStatus": "COMPLETED",
    "conditions": "Atypical Ductal Hyperplasia (ADH) of the Breast",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 9,
    "primaryOutcomeMeasure": "Findings of palpable mass or imaging abnormality (increase in size or in the amount of calcifications)",
    "eligibilityCriteria": "Inclusion Criteria\n\nA patient/subject is eligible for enrollment if all of the following inclusion criteria are met:\n\n1. Pre- and post-menopausal women \u2265 40 years of age with newly diagnosed ADH, histologically confirmed on breast core biopsy.\n2. Ability to understand and the willingness to sign a written informed consent document.\n3. Willing to schedule definitive resection of ADH if randomized to surgical excision arm or be observed if randomized to the observation arm.\n4. Original breast core biopsy specimen available for pathologic review and staining by Yale School of Medicine Department of Pathology.\n\nExclusion Criteria\n\nA patient/subject will not be eligible for this study if any of the following exclusion criteria are met:\n\n1. Patients with a current breast cancer diagnosis or a personal history of cancer\n2. Patients with a personal history of an identifiable genetic mutation (BRCA) for breast cancer and, untested first degree relatives of mutation carriers\n3. Patients who have previously or are currently taking tamoxifen or exemestane or other chemotherapy or biologic therapy (e.g. trastuzumab)\n4. Patients with a history of radiation therapy to the chest wall\n5. Pregnant and/or lactating women within past 6 months.",
    "sex": "FEMALE",
    "minimumAge": "40 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}